Folder slides

Documents

pdf Abha Saxena_Ethical considerations for Human Challenge Studies The WHO perspective

By 32 downloads

Download (pdf, 2.44 MB)

Abha Saxena_Ethical considerations for Human Challenge Studies-The WHO perspective.pdf

pdf Alan Fauconnier_The status of challenge material within the EU regulatory framework

By 22 downloads

Download (pdf, 798 KB)

Alan Fauconnier_The status of challenge material within the EU regulatory framework.pdf

pdf Alan Fix_Challenge assessment of a novel rotavirus vaccine

By 17 downloads

Download (pdf, 992 KB)

Alan Fix_Challenge assessment of a novel rotavirus vaccine.pdf

pdf Anna Durbin_Dengue infection model

By 18 downloads

Download (pdf, 1.38 MB)

Anna Durbin_Dengue infection model.pdf

pdf Anna Durbin_Role of a ZIKV CHIM in vaccine evaluation

By 19 downloads

Download (pdf, 1.42 MB)

Anna Durbin_Role of a ZIKV CHIM in vaccine evaluation.pdf

pdf Beth D. Kirkpatrick_CHIM opportunities in human immunology

By 20 downloads

Download (pdf, 2.38 MB)

Beth D. Kirkpatrick_CHIM-Opportunities in human immunology.pdf

pdf Bridget Wills_A dengue Controlled Human Infection Model in Vietnam

By 17 downloads

Download (pdf, 1.96 MB)

Bridget Wills_A dengue Controlled Human Infection Model in Vietnam .pdf

pdf Bruno Speder_Regulatory considerations regarding the development of the SGS A Belgium 4217 2015 H3N2 challenge agent

By 18 downloads

Download (pdf, 945 KB)

Bruno Speder_Regulatory considerations regarding the development of the SGS A-Belgium-4217-2015 H3N2 challenge agent.pdf

pdf Caroline Lyon_A CHIM site's experience with an FDA inspection New

By 6 downloads

Download (pdf, 472 KB)

Caroline Lyon_A CHIM site's experience with an FDA inspection.pdf

pdf Chad Porter_Development, use and refinement of enterotoxigenic Escherichia coli (ETEC) controlled human infection

By 16 downloads

Download (pdf, 1.43 MB)

Chad Porter_Development, use and refinement of enterotoxigenic Escherichia coli (ETEC) controlled human infection.pdf

pdf Christopher Chiu Dissecting immunity to RSV using Human Challenge Trials New

By 19 downloads

Download (pdf, 2.02 MB)

Christopher Chiu_Dissecting immunity to RSV using Human Challenge Trials.pdf

pdf David Tribble Enteric pathogen safety considerations in Human Challenge Trials

By 23 downloads

Download (pdf, 345 KB)

David Tribble_Enteric pathogen safety considerations in Human Challenge Trials.pdf

pdf Dominique Ploin Imperative to develop vaccines for children, pregnant women, the immunocomprressed HCTs in vulnerables can we break the rules

By 20 downloads

Download (pdf, 6.64 MB)

Dominique Ploin_Imperative to develop vaccines for children, pregnant women, the immunocomprressed-HCTs in vulnerables-can we break the rules.pdf

pdf Helen McShane_Developing a human mycobacterial challenge model

By 18 downloads

Download (pdf, 1.53 MB)

Helen McShane_Developing a human mycobacterial challenge model.pdf

pdf Ivana Knezevic_WHO Guidelines New

By 11 downloads

Download (pdf, 1.49 MB)

Ivana Knezevic_WHO Guidelines.pdf

pdf John Treanor_Pediatric influenza and rotavirus challenge models

By 19 downloads

Download (pdf, 667 KB)

John Treanor_Pediatric influenza and rotavirus challenge models.pdf

pdf Jona Walk_Managing safety in Controlled Human Malaria Infections New

By 10 downloads

Download (pdf, 792 KB)

Jona Walk_Managing safety in Controlled Human Malaria Infections.pdf

pdf Marc Gurwith_Cholera Human Challenge as pivotal efficacy study

By 20 downloads

Download (pdf, 1.12 MB)

Marc Gurwith_Cholera Human Challenge as pivotal efficacy study.pdf

pdf Mark Riddle Bioconjugate vaccine preventing shigellosis bridge from HCT to field studies

By 23 downloads

Download (pdf, 1.70 MB)

Mark Riddle_Bioconjugate vaccine preventing shigellosis-bridge from HCT to field studies.pdf

pdf Michael Pfleiderer_Quality standards for challenge strains

By 23 downloads

Download (pdf, 798 KB)

Michael Pfleiderer_Quality standards for challenge strains.pdf

International Alliance for Biological Standardization


Twitter Feed

#IABS #NextGeneration Sequencing for#AdventitiousVirus detection in #biologics October 26-27 https://t.co/Hleep8TKDU
#IABS #NextGenerationSequencing #AdventitiousVirus detection #biologics: Reference tools for #adventitiousvirus detection by #metagenomics
Follow IABS_global on Twitter

Contact Info

IABS, Rue de la Vallée, 3
CH-1204 Geneva

Switzerland
+ 41 22 301 10 36
+ 41 22 301 10 37
This email address is being protected from spambots. You need JavaScript enabled to view it.